Patent details
EP3496743 Title: COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ARGININE DEPLETION AND IMMUNO ONCOLOGY AGENTS
Basic Information
- Publication number:
- EP3496743
- PCT Application Number:
- US2017050816
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178404208
- PCT Publication Number:
- WO2018032020
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ARGININE DEPLETION AND IMMUNO ONCOLOGY AGENTS
- French Title of Invention:
- COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DU CANCER PAR DÉPLÉTION EN ARGININE ET À L'AIDE D'AGENTS D'IMMUNO-ONCOLOGIE
- German Title of Invention:
- ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON KREBS MIT ARGININDEPLETION UND IMMUNONKOLOGIEWIRKSTOFFEN
- SPC Number:
Dates
- Filing date:
- 08/09/2017
- Grant date:
- 09/02/2022
- EP Publication Date:
- 19/06/2019
- PCT Publication Date:
- 15/02/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/02/2022
- EP B1 Publication Date:
- 09/02/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/09/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/10/2023
- Name:
- Immedica Pharma AB
- Address:
- Solnavägen 3H, 113 63, Stockholm, Sweden (SE)
History of Owners
- From:
- 02/02/2022
- To:
- 27/10/2023
- Name:
- AERase, Inc.
- Address:
- 901 S. Mopac Expressway Barton Oaks Plaza One, Suite 250, Austin, TX 78746, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 14/02/2022
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- LOWE, David
- Address:
- United States (US)
2
- Name:
- ALTERS, Susan
- Address:
- United States (US)
3
- Name:
- ROWLINSON, Scott, W.
- Address:
- United States (US)
4
- Name:
- AGNELLO, Giulia
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662372092 P
- Priority Date:
- 08/08/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762524286 P
- Priority Date:
- 23/06/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/50; A61K 39/00; C07K 16/28; C12N 9/78; A61P 35/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2023/13
- Publication date:
- 07/12/2023
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 202206
- Publication date:
- 09/02/2022
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000466A
- Date Registered:
- 27/10/2023
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Immedica Pharma AB
- Address:
- Solnavägen 3H, 113 63, Stockholm, Sweden (SE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/08/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- ZACCO DENMARK A/S
| Filing date | Document type | Number of pages |
|---|---|---|
| 27/10/2023 | Request For Change | 30 |
| 10/11/2023 | Outgoing Correspondence | 1 |
| 14/02/2022 | Power Of Attorney | 1 |
| 15/02/2022 | Outgoing Correspondence | 1 |